Patients with primary Sjögren syndrome have an increased risk of lymphoma or lymphoproliferative disease compared to the general population and ascertaining relevant and reliable predictors would greatly facilitate the identification of patients at elevated risk for closer monitoring. PubMed, Rheumatol Int, 2014 Jun 5. (Also see: Sjogren's Syndrome)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.